RB

Ravinder Bhat

Active Director Director DIN 00371081
DIN 00371081 First appointment Jul 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Ravinder Bhat

Data last updated:

Ravinder Bhat is a Director at Advance Mediplus Private Limited (since 2017). The company operates in Healthcare. Advance Mediplus Private Limited reported revenue of ₹1.14 Cr (FY 2024).

DIN 00371081
Primary Designation Director
Industry Healthcare
First Appointment 31 Jul 2017
Oldest Company Age 27 yrs
Largest company Advance Mediplus Private Limited · ₹1.14 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advance Mediplus Private Limited U51507DL1999PTC098453
Director31 Jul 20171999₹1.14 Cr (FY 2024)Active

Board colleagues of Ravinder Bhat

Directorship timeline

Open interactive timeline →
Advance Mediplus Private Limited
Premium access

Shareholding and investment profile for Ravinder Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravinder Bhat

Ravinder Bhat currently holds 1 directorship: Advance Mediplus Private Limited (Director, since 31 Jul 2017, revenue ₹1.14 Cr (FY 2024)).

Ravinder Bhat was first appointed on 31 Jul 2017 as Director at Advance Mediplus Private Limited.

The current boards of Ravinder Bhat's companies include Pawan Singh Mongia (Advance Mediplus Private Limited), Sunil Kumar Chhillar (Advance Mediplus Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available